51 -7 (45) 2022 — Sabirov D.R., Romanovskaya T.A. — HEALTH CARE DURING THE COVID-19 PANDEMIC: INTERNATIONAL EXPERIENCE AND ACHIEVEMENTS

HEALTH CARE DURING THE COVID-19 PANDEMIC: INTERNATIONAL EXPERIENCE AND ACHIEVEMENTS

Sabirov D.R. Tashkent Medical Academy, LLC “Progressive Medical Service”,

Romanovskaya T.A LLC “Progressive Medical Service”,

Akhmedova M.D., Tashkent Medical Academy,

Yusupova O.Zh., Tashkent Medical Academy,

Oblokulov A.R., Bukhara State Medical Institute named after Abu Ali ibn Sino

Nazirov Sh.A. Tashkent Medical Academy,

Resume

The global outbreak of the novel coronavirus disease (COVID-19) has affected every aspect of human life. Despite the measures taken to combat the spread of the virus, the public health system of many countries has shown itself to be ineffective. This publication presents the results of studying the characteristics of the response of different health systems in various countries to the COVID-19 pandemic by analyzing the available scientific literature. The economic activity of states is gradually recovering. Possible ways to achieve unified effective approaches on a global scale, the creation of unified state response systems are described. It is expected that the proper implementation of the proposed strategies can increase the effectiveness of anti-epidemic measures in all countries of the world.

Keywords: COVID-19 pandemic, healthcare, epidemic.

Fist page

256

Last page

262

For citation: Sabirov D.R, Romanovskaya T.A., Akhmedova M.D., Yusupova O.Zh., Oblokulov A.R.,, Nazirov Sh.A. HEALTH CARE DURING THE COVID-19 PANDEMIC: INTERNATIONAL EXPERIENCE AND ACHIEVEMENTS //New Day in medicine 7(45)2022 256-262 https://clck.ru/sKyCE

LIST OF REFERENCES:

1. Забелин С.А. США, ЕВРОСОЮЗ и Россия: пандемия COVID-19 и новая реальность. Научно-аналитический Вестник Института Европы РАН. 2020. №3.
2. Кудрявцева О.В. COVID-19: советы кардиолога. Здравоохранение Югры: опыт и инновации. 2020. №1.
3. Постановление Президента Республики Узбекистан № ПП-4649 от 26 марта 2020 года «О дополнительных мерах по предупреждению широкого распространения коронавирусной инфекции в Республике Узбекистан»;
4. Постановление Президента Республики Узбекистан № ПП-4790 от 27 июля 2020 года «О мерах по организации деятельности службы санитарно- эпидемиологического благополучия и общественного здоровья Республики Узбекистан»;
5. Постановление Президента Республики Узбекистан № ПП-4790 от 27 июля 2020 года «О мерах по организации деятельности службы санитарно- эпидемиологического благополучия и общественного здоровья Республики Узбекистан»;
6. Постановление Кабинета Министров РУз№ 446 от 20 июля 2020 года «О мерах по широкому охвату населения службой скорой медицинской помощи в период борьбы с коронавирусной инфекцией».
7. Сабиров Д.Р, Хусанов А.М., Шамсутдинова М.И., Юсупова О.Ж., Романовская Т.А. Здравоохранение в эпоху пандемии через призму времени: международный опыт и достижения в борьбе с COVID-19. Инфекция, Иммунитет и Фармакология, №4, 2021, стр. 5-15.
8. Abbo AR, Miller A, Gazit Т, Savir Y, Caspi О. Technological Developments and Strategic Management for Overcoming the COVID-19 Challenge within the Hospital Setting in Israel. Rambam Maimonides Med J. 2020;11(3):10.5041/RMMJ.10417.
9. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, Introduction to Meta-Analysis,p. 190. analysis/Metaregression.pdf. Accessed July 8, 2020.
10. Brueckner M, Titman A, Jaki T, Rojek A, Horby P. Performance of different clinical trial designs to evaluate treatments during an epidemic. PLoS One. 2018;13:e0203387.
11. Merkel Announces Strict Measures and Tells Germans to Stay Home in Virus Fighle. Available online: https://www.france24.com/en/20200317-merkel- announces-strict-measures-and-tellsgermans-to-stay-home-in-virus-fight. (accessed on 21 July 2020).
12. Carenzo L, Costantini E, Greco M, et al. Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia. 2020;75(7):928-934.
13. Chang De, Xu Huiwen, Rebaza Andre, Sharma Lokesh, Dela Cruz Charles S. Protecting health-care workers from subclinical coronavirus infection. The Lancet Respiratory Medicine. 2020;8(3):el3.
14. Cheng Z.J., Shan J. 2019 novel coronavirus: where we are and what we know. Infection. 2020:1-9. 10.1007/s 15010-020-01401 -y.
15. Kampf G., Todt D., Pfaender S., Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020 Feb 6. pii: SO 195-6701(20)30046-3.
16. Kannan S., Shaik Syed Ali P, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus 2019) – recent trends. //Eur Rev Med Pharmacol Sci. 2020;24(4):2006-2011.
17. Jia H.P., Min Wu. Sustained research fund and dedicated research center for preparing next pandemic, Precision Clinical Medicine, pbaa012.
18. Li J., Huang D.Q., Zou B., et al. Epidemiology of COVID-19: A systematic review and metaanalysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2020; 1-11.
19. Mizumoto К., Chowell G. Estimating risk for death from 2019 novel coronavirus disease, China, January-February 2020. Emerging Infect Dis. 2020;26:26-1256.
20. Mizumoto K., Kagaya K., Zarebski A., Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25(10):2000180.